Skip to content

Optimizing Cardiac Resynchronization

Optimizing Cardiac Resynchronization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00205192
Enrollment
100
Registered
2005-09-20
Start date
2004-06-30
Completion date
2011-12-31
Last updated
2012-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, Cardiac resynchronization, echocardiography

Brief summary

Cardiac resynchronization therapy shows great promise as a method to improve ventricular function in heart failure due to dilated cardiomyopathy. It is applied to patients with class III and IV symptomatic heart failure on optimal therapy. Typical entry criteria in the trials testing resynchronization have used the electrocardiogram and a prolonged electrocardiogram (ECG) QRS interval as criteria for dyssynchrony. This is recognized to be quite limited as a tool for identifying patients. Several new echocardiographic methods for identifying dyssynchrony have been proposed. The purpose of this study is to systematically examine these multiple echocardiographic measurement techniques in three conditions: 1. in the patient's native rhythm simulated by changing the pacing system to atrial pacing only; 2. in conventional dual chamber pacing (DDD mode); and 3. during biventricular pacing. All patients entered into this study will already have had a biventricular pacemaker placed.

Interventions

various pacemaker modes used over 1 hour

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients who have previously had a resynchronization pacemaker system placed at the University of Wisconsin Hospital or at the Middleton Veterans Hospital are potentially eligible for this study. * The study is only open to patients as enumerated above, and also patients who have good imaging windows.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026